MAKENZA 160MG

Product Description

• Active Ingredient: Enzalutamide (160 mg strength)
• Manufacturer/Marketer: Biomak Laboratories Pvt Ltd
• Mechanism of Action: Enzalutamide is an androgen receptor inhibitor (blocker). It works by blocking testosterone (a male hormone) from reaching prostate cancer cells, which slows the cancer's growth or causes it to shrink.
• Form: Tablet or Capsule, for oral consumption. 

• Makenza is a prescription drug for men only and requires medical guidance.
• Men using Makenza must use effective contraception during treatment and for three months afterward due to potential risks to an unborn baby. It is not for women, especially if pregnant or breastfeeding.
• Common side effects include fatigue, back and joint pain, headache, high blood pressure, and sleep difficulties. Seizures are a rare but possible side effect.